MX2024000361A - Metodo para neutralizar el ácido del estómago utilizando alginato, polilisina y conservantes de semillas. - Google Patents
Metodo para neutralizar el ácido del estómago utilizando alginato, polilisina y conservantes de semillas.Info
- Publication number
- MX2024000361A MX2024000361A MX2024000361A MX2024000361A MX2024000361A MX 2024000361 A MX2024000361 A MX 2024000361A MX 2024000361 A MX2024000361 A MX 2024000361A MX 2024000361 A MX2024000361 A MX 2024000361A MX 2024000361 A MX2024000361 A MX 2024000361A
- Authority
- MX
- Mexico
- Prior art keywords
- alginate
- polylysine
- preservatives
- seed
- stomach acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163218488P | 2021-07-05 | 2021-07-05 | |
| PCT/US2022/035992 WO2023283143A2 (en) | 2021-07-05 | 2022-07-01 | Method for neutralizing stomach acid using alginate, polylysine, and seed preservatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024000361A true MX2024000361A (es) | 2024-04-16 |
Family
ID=84785812
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024000361A MX2024000361A (es) | 2021-07-05 | 2022-07-01 | Metodo para neutralizar el ácido del estómago utilizando alginato, polilisina y conservantes de semillas. |
| MX2024000360A MX2024000360A (es) | 2021-07-05 | 2022-07-01 | Producto nutricional y auxiliar digestivo de alginato, polilisina y conservante de semillas. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024000360A MX2024000360A (es) | 2021-07-05 | 2022-07-01 | Producto nutricional y auxiliar digestivo de alginato, polilisina y conservante de semillas. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230000900A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4366742A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024525096A (cg-RX-API-DMAC7.html) |
| CN (2) | CN117980012A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022308346A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3224252A1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2024000361A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023283143A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117980012A (zh) * | 2021-07-05 | 2024-05-03 | 雷鲁克斯美食有限责任公司 | 海藻酸盐、聚赖氨酸和种子防腐剂营养产品和消化助剂 |
| WO2024164046A1 (en) * | 2023-02-07 | 2024-08-15 | Satiex IP Pty Ltd | Methods and compositions |
| US20240423938A1 (en) * | 2023-06-26 | 2024-12-26 | Reflux Gourmet Llc | Functional gum comprising an alginate blend |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3951821A (en) * | 1972-07-14 | 1976-04-20 | The Dow Chemical Company | Disintegrating agent for tablets |
| FR2642617B1 (fr) * | 1989-02-07 | 1991-12-27 | Bio Hyles | Procede pour ameliorer le sechage naturel des produits biologiques, et produits biologiques ainsi traites |
| US5411988A (en) * | 1993-10-27 | 1995-05-02 | Bockow; Barry I. | Compositions and methods for inhibiting inflammation and adhesion formation |
| GB9322314D0 (en) * | 1993-10-29 | 1993-12-15 | Scherer Ltd R P | Foam generating capsules |
| AU8000494A (en) * | 1993-10-29 | 1995-05-22 | Reckitt & Colman Products Limited | Gelatin capsule fill able to foam |
| GB2298365B (en) * | 1995-03-03 | 1997-05-07 | Reckitt & Colmann Prod Ltd | A liquid pharmaceutical composition alginate and potassium bicarbonate |
| GB2328443B (en) * | 1997-08-21 | 2001-09-05 | Reckitt & Colmann Prod Ltd | In situ formation of pharmaceutically acceptable polymeric material |
| JPH11116935A (ja) * | 1997-10-16 | 1999-04-27 | Susumu Kawashima | パントテン酸カルシウムを用いたゲルの調製方法 |
| WO2000011956A1 (en) * | 1998-08-27 | 2000-03-09 | Bio Venture Bank Co., Ltd. | Bacteriostatic and bactericidal compositions and method for utilization thereof |
| GB0012094D0 (en) * | 2000-05-19 | 2000-07-12 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| US20070178150A1 (en) * | 2003-07-10 | 2007-08-02 | Prasad Adusumilli | Pharmaceutical compositions |
| JP2005047809A (ja) * | 2003-07-29 | 2005-02-24 | Taisho Pharmaceut Co Ltd | 内服用ゲル状組成物 |
| BRPI0912195A2 (pt) * | 2008-05-09 | 2019-09-24 | Cargill Inc | xaropes com açúcar reduzido e baixa viscosidade, métodos de preparação e uso dos mesmos. |
| WO2010108494A1 (en) * | 2009-03-25 | 2010-09-30 | S-Biotek Holding Aps | Dayspepsia treatment with alginate |
| AU2011242177B8 (en) * | 2010-04-23 | 2015-06-04 | S-Biotek Holding Aps | A solid pharmaceutical composition for neutralizing stomach acid |
| US9198873B2 (en) * | 2010-07-19 | 2015-12-01 | National Cheng Kung University | Functionalized nanoparticle, method for preparing the same and application thereof |
| KR101110271B1 (ko) * | 2011-07-14 | 2012-02-15 | 팜드림주식회사 | 기능성 알긴산 비드를 함유한 유제품 및 이의 제조 방법 |
| HUE025008T2 (en) * | 2012-10-12 | 2016-04-28 | Omya Int Ag | Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate |
| BR102016030321B1 (pt) * | 2016-12-22 | 2021-05-04 | Universidade Federal De Pernambuco | hidrogel de alginato contendo vitaminas do complexo b, resveratrol e carvacrol para cicatrização de ferimentos cutâneos |
| US11110118B2 (en) * | 2018-03-02 | 2021-09-07 | Pharagen Llc | Formulations for treating acid reflux comprising sodium alginate |
| CN117980012A (zh) * | 2021-07-05 | 2024-05-03 | 雷鲁克斯美食有限责任公司 | 海藻酸盐、聚赖氨酸和种子防腐剂营养产品和消化助剂 |
| US20240423938A1 (en) * | 2023-06-26 | 2024-12-26 | Reflux Gourmet Llc | Functional gum comprising an alginate blend |
-
2022
- 2022-07-01 CN CN202280059536.3A patent/CN117980012A/zh active Pending
- 2022-07-01 MX MX2024000361A patent/MX2024000361A/es unknown
- 2022-07-01 AU AU2022308346A patent/AU2022308346A1/en active Pending
- 2022-07-01 EP EP22838285.9A patent/EP4366742A4/en not_active Withdrawn
- 2022-07-01 WO PCT/US2022/035992 patent/WO2023283143A2/en not_active Ceased
- 2022-07-01 JP JP2024500622A patent/JP2024525096A/ja active Pending
- 2022-07-01 AU AU2022306572A patent/AU2022306572A1/en active Pending
- 2022-07-01 US US17/856,542 patent/US20230000900A1/en active Pending
- 2022-07-01 CA CA3224252A patent/CA3224252A1/en active Pending
- 2022-07-01 MX MX2024000360A patent/MX2024000360A/es unknown
- 2022-07-01 JP JP2024500611A patent/JP2024525095A/ja active Pending
- 2022-07-01 CA CA3224263A patent/CA3224263A1/en active Pending
- 2022-07-01 WO PCT/US2022/035986 patent/WO2023283141A1/en not_active Ceased
- 2022-07-01 CN CN202280059601.2A patent/CN118284424A/zh active Pending
- 2022-07-01 US US17/856,527 patent/US20230000899A1/en active Pending
- 2022-07-01 EP EP22838283.4A patent/EP4366792A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230000900A1 (en) | 2023-01-05 |
| US20230000899A1 (en) | 2023-01-05 |
| EP4366792A1 (en) | 2024-05-15 |
| CN117980012A (zh) | 2024-05-03 |
| MX2024000360A (es) | 2024-04-16 |
| EP4366792A4 (en) | 2025-05-28 |
| CA3224252A1 (en) | 2023-01-12 |
| EP4366742A2 (en) | 2024-05-15 |
| WO2023283141A1 (en) | 2023-01-12 |
| JP2024525096A (ja) | 2024-07-09 |
| JP2024525095A (ja) | 2024-07-09 |
| WO2023283143A2 (en) | 2023-01-12 |
| AU2022308346A1 (en) | 2024-02-22 |
| WO2023283143A3 (en) | 2023-03-02 |
| EP4366742A4 (en) | 2025-09-17 |
| CN118284424A (zh) | 2024-07-02 |
| AU2022306572A1 (en) | 2024-02-22 |
| CA3224263A1 (en) | 2023-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2023283143A3 (en) | Method for neutralizing stomach acid using alginate, polylysine, and seed preservatives | |
| MX2020013192A (es) | Metodo y formulacion para mejorar el tiempo de retraso de penetracion en la piel de roflumilast. | |
| WO2019199861A3 (en) | Hemp extract for treatment of pain in animals | |
| PE20190451A1 (es) | Composiciones que comprenden cepas bacterianas | |
| WO2016190683A8 (ko) | 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
| CN104886707A (zh) | 果蔬复合代餐固体养生抗癌饮料及其制备方法 | |
| BR112017007308A2 (pt) | composição, método para produzir a composição, usos de uma composição e método para aumentar a produção de gordura de leite em um ruminante lactante | |
| CN104000773A (zh) | 一种天然抗氧化组合化妆品及其制备方法 | |
| CN105362148A (zh) | 一种脸部紧致复合物、快速提拉紧实面膜乳及制备方法 | |
| CN104382036B (zh) | 女性日用保健品 | |
| CN108785459A (zh) | 一种适合孕妇用的祛斑组合物及其应用 | |
| TW201442717A (zh) | 兼具抗癌、降低肺部纖維化功效的桑黃合併抗癌藥之複合組成物 | |
| CN106137891A (zh) | 一种富含海洋生物添加剂的美白面膜 | |
| CN114732130B (zh) | 含雨生红球藻且抑制胃粘膜受损的组合物及其应用 | |
| KR102101566B1 (ko) | 모세혈관 출혈 개선 및 방지용 건강기능식품 | |
| TN2022000199A1 (en) | Formulation of a nutraceutical product based on nano-emulsion of grapeseed oil for the treatment of stomach ulcers | |
| CN107549475A (zh) | 一种水蛭用的营养配料 | |
| Fever | Dengue Fever | |
| MX2018005881A (es) | Suplemento dietético que comprende beta-glucano e hidrolizado de caseína para mejorar la salud y el desempeño del crecimiento de un mamifero. | |
| CO2021011791A1 (es) | Alimento funcional viscoso azucarado a base de citral | |
| PH22021050366U1 (en) | FORMULATION OF CRANBERRY (Vaccinium Subg. Oxcycocus) MARMALADE ENRICHED WITH TURMERIC (Curcuma longa) AND FLAVORED WITH HONEY. | |
| CN105029538A (zh) | 一种芹菜瘦身汤 | |
| CN104398820A (zh) | 中药消痘液 | |
| PH22019001032U1 (en) | Composition of producing nipa palm (nypa fruticans) jam | |
| CN108077697A (zh) | 一种可恢复青少年体能的运动饮料 |